Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 88

1.

Factor VIII inhibitor: affinity is the clue.

Jacquemin M, Peerlinck K.

Blood. 2015 Feb 12;125(7):1056-8. doi: 10.1182/blood-2014-12-618991. No abstract available.

PMID:
25678435
2.

Response: Extended analysis of microarray data does not contradict preplasmablast phenotype of human CD20+CD27+CD43+ cells.

Covens K, Verbinnen B, Jacquemin M, Bossuyt X.

Blood. 2013 Nov 21;122(22):3693-4. doi: 10.1182/blood-2013-09-528091. No abstract available.

3.

Human liver sinusoidal endothelial cells but not hepatocytes contain factor VIII.

Shahani T, Covens K, Lavend'homme R, Jazouli N, Sokal E, Peerlinck K, Jacquemin M.

J Thromb Haemost. 2014 Jan;12(1):36-42. doi: 10.1111/jth.12412.

PMID:
24118899
4.

Calibration of the X-ray photoelectron spectroscopy binding energy scale for the characterization of heterogeneous catalysts: is everything really under control?

Jacquemin M, Genet MJ, Gaigneaux EM, Debecker DP.

Chemphyschem. 2013 Oct 21;14(15):3618-26. doi: 10.1002/cphc.201300411. Epub 2013 Sep 5.

PMID:
24009131
5.

Characterization of proposed human B-1 cells reveals pre-plasmablast phenotype.

Covens K, Verbinnen B, Geukens N, Meyts I, Schuit F, Van Lommel L, Jacquemin M, Bossuyt X.

Blood. 2013 Jun 27;121(26):5176-83. doi: 10.1182/blood-2012-12-471953. Epub 2013 Apr 23.

6.

Time course of acquired von Willebrand disease associated with two types of continuous-flow left ventricular assist devices: HeartMate II and CircuLite Synergy Pocket Micro-pump.

Goda M, Jacobs S, Rega F, Peerlinck K, Jacquemin M, Droogne W, Vanhaecke J, Van Cleemput J, Van den Bossche K, Meyns B.

J Heart Lung Transplant. 2013 May;32(5):539-45. doi: 10.1016/j.healun.2013.02.006.

PMID:
23570742
7.

Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial.

Goossens GA, Jérôme M, Janssens C, Peetermans WE, Fieuws S, Moons P, Verschakelen J, Peerlinck K, Jacquemin M, Stas M.

Ann Oncol. 2013 Jul;24(7):1892-9. doi: 10.1093/annonc/mdt114. Epub 2013 Apr 3.

8.

Anticoagulation with fondaparinux for hemodiafiltration in patients with heparin-induced thrombocytopenia: dose-finding study and safety evaluation.

Mahieu E, Claes K, Jacquemin M, Evenepoel P, Op De Beek K, Bogaert AM, Kuypers D, Verhamme P, Meijers B.

Artif Organs. 2013 May;37(5):482-7. doi: 10.1111/aor.12002. Epub 2013 Mar 5.

PMID:
23461610
9.

Practical and cost-effective measurement of B-domain deleted and full-length recombinant FVIII in the routine haemostasis laboratory.

Cauchie M, Toelen J, Peerlinck K, Jacquemin M.

Haemophilia. 2013 May;19(3):e133-8. doi: 10.1111/hae.12093. Epub 2013 Feb 4.

PMID:
23374099
10.

Increased synapse formation obtained by T cell epitopes containing a CxxC motif in flanking residues convert CD4+ T cells into cytolytic effectors.

Carlier VA, VanderElst L, Janssens W, Jacquemin MG, Saint-Remy JM.

PLoS One. 2012;7(10):e45366. doi: 10.1371/journal.pone.0045366. Epub 2012 Oct 9.

11.

Antidote strategies to reverse anticoagulation with TB-402, a long-acting partial inhibitor of factor VIII.

Tangelder M, Long C, Emmerechts J, Jacquemin M, Peerlinck K, Vanassche T, Glazer S, Giesen P, Hoylaerts M, Verhamme P.

J Thromb Haemost. 2012 Jul;10(7):1371-8. doi: 10.1111/j.1538-7836.2012.04762.x.

PMID:
22540161
12.

Evaluation of the prothrombin time for measuring rivaroxaban plasma concentrations using calibrators and controls: results of a multicenter field trial.

Samama MM, Contant G, Spiro TE, Perzborn E, Flem LL, Guinet C, Gourmelin Y, Martinoli JL; Rivaroxaban Prothrombin Time Field Trial Laboratories.

Clin Appl Thromb Hemost. 2012 Mar-Apr;18(2):150-8. doi: 10.1177/1076029611426282. Epub 2012 Mar 2.

PMID:
22387577
13.

Evaluation of the anti-factor Xa chromogenic assay for the measurement of rivaroxaban plasma concentrations using calibrators and controls.

Samama MM, Contant G, Spiro TE, Perzborn E, Guinet C, Gourmelin Y, Le Flem L, Rohde G, Martinoli JL; Rivaroxaban Anti-Factor Xa Chromogenic Assay Field Trial Laboratories.

Thromb Haemost. 2012 Feb;107(2):379-87. doi: 10.1160/TH11-06-0391. Epub 2011 Dec 21.

PMID:
22187012
14.

A randomized clinical trial comparing point-of-care platelet function assays and bleeding time in healthy subjects treated with aspirin or clopidogrel.

Chen F, Maridakis V, O'neill EA, Beals C, Radziszewski W, de Lepeleire I, Van Dyck K, Depré M, Bolognese JA, de Hoon J, Jacquemin M.

Platelets. 2012;23(4):249-58. doi: 10.3109/09537104.2011.604806. Epub 2011 Sep 15.

PMID:
21919555
15.

Partial versus complete factor VIII inhibition in a mouse model of venous thrombosis.

Emmerechts J, Vanassche T, Loyen S, Van Linthout I, Cludts K, Kauskot A, Long C, Jacquemin M, Hoylaerts MF, Verhamme P.

Thromb Res. 2012 Apr;129(4):514-9. doi: 10.1016/j.thromres.2011.06.027. Epub 2011 Jul 20.

PMID:
21777952
16.

Successful immune tolerance induction by FVIII in hemophilia A patients with inhibitor may occur without deletion of FVIII-specific T cells.

Pautard B, D'Oiron R, Li Thiao Te V, Lavend'homme R, Saint-Remy JM, Peerlinck K, Jacquemin M.

J Thromb Haemost. 2011 Jun;9(6):1163-70. doi: 10.1111/j.1538-7836.2011.04267.x.

PMID:
21645224
17.

Single intravenous administration of TB-402 for the prophylaxis of venous thromboembolism after total knee replacement: a dose-escalating, randomized, controlled trial.

Verhamme P, Tangelder M, Verhaeghe R, Ageno W, Glazer S, Prins M, Jacquemin M, Büller H; TB-402 Study Group.

J Thromb Haemost. 2011 Apr;9(4):664-71. doi: 10.1111/j.1538-7836.2011.04221.x.

PMID:
21284801
18.

Retroviral vectors induce epigenetic chromatin modifications and IL-10 production in transduced B cells via activation of toll-like receptor 2.

Ahangarani RR, Janssens W, Carlier V, Vanderelst L, Vandendriessche T, Chuah M, Jacquemin M, Saint-Remy JM.

Mol Ther. 2011 Apr;19(4):711-22. doi: 10.1038/mt.2010.275. Epub 2010 Dec 14.

19.

A membrane-interactive surface on the factor VIII C1 domain cooperates with the C2 domain for cofactor function.

Lü J, Pipe SW, Miao H, Jacquemin M, Gilbert GE.

Blood. 2011 Mar 17;117(11):3181-9. doi: 10.1182/blood-2010-08-301663. Epub 2010 Dec 14.

20.

Tolerability and pharmacokinetics of TB-402 in healthy male volunteers.

Verhamme P, Pakola S, Jensen TJ, Berggren K, Sonesson E, Saint-Remy JM, Balchen T, Belmans A, Cahillane G, Stassen JM, Peerlinck K, Glazer S, Jacquemin M.

Clin Ther. 2010 Jun;32(6):1205-20. doi: 10.1016/j.clinthera.2010.06.012.

PMID:
20637972
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk